Aurinia Pharmaceuticals Inc (AUPH)
8.77
+0.53
(+6.43%)
USD |
NASDAQ |
Nov 21, 16:00
8.76
-0.01
(-0.11%)
Pre-Market: 08:47
Aurinia Pharmaceuticals Price to Book Value: 3.236 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 21, 2024 | 3.236 |
November 20, 2024 | 3.041 |
November 19, 2024 | 3.000 |
November 18, 2024 | 2.956 |
November 15, 2024 | 2.996 |
November 14, 2024 | 3.074 |
November 13, 2024 | 3.056 |
November 12, 2024 | 3.092 |
November 11, 2024 | 3.133 |
November 08, 2024 | 3.070 |
November 07, 2024 | 3.078 |
November 06, 2024 | 2.775 |
November 05, 2024 | 2.700 |
November 04, 2024 | 2.659 |
November 01, 2024 | 2.700 |
October 31, 2024 | 2.659 |
October 30, 2024 | 2.715 |
October 29, 2024 | 2.763 |
October 28, 2024 | 2.670 |
October 25, 2024 | 2.600 |
October 24, 2024 | 2.597 |
October 23, 2024 | 2.578 |
October 22, 2024 | 2.608 |
October 21, 2024 | 2.645 |
October 18, 2024 | 2.593 |
Date | Value |
---|---|
October 17, 2024 | 2.648 |
October 16, 2024 | 2.648 |
October 15, 2024 | 2.656 |
October 14, 2024 | 2.626 |
October 11, 2024 | 2.611 |
October 10, 2024 | 2.574 |
October 09, 2024 | 2.490 |
October 08, 2024 | 2.516 |
October 07, 2024 | 2.523 |
October 04, 2024 | 2.626 |
October 03, 2024 | 2.589 |
October 02, 2024 | 2.626 |
October 01, 2024 | 2.678 |
September 30, 2024 | 2.704 |
September 27, 2024 | 2.855 |
September 26, 2024 | 2.808 |
September 25, 2024 | 2.824 |
September 24, 2024 | 2.753 |
September 23, 2024 | 2.737 |
September 20, 2024 | 2.824 |
September 19, 2024 | 2.824 |
September 18, 2024 | 2.777 |
September 17, 2024 | 2.800 |
September 16, 2024 | 2.796 |
September 13, 2024 | 2.757 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.379
Minimum
Dec 27 2022
18.88
Maximum
Dec 26 2019
4.565
Average
3.860
Median
Price to Book Value Benchmarks
Edesa Biotech Inc | 2.390 |
Lexaria Bioscience Corp | 3.374 |
Xenon Pharmaceuticals Inc | 3.803 |
ESSA Pharma Inc | 0.606 |
ImmunoPrecise Antibodies Ltd | 0.41 |
Price to Book Value Related Metrics
PS Ratio | 5.746 |
Price to Free Cash Flow | 44.73 |
Price | 8.77 |
Earnings Yield | -1.60% |
Market Cap | 1.256B |